James Wentworth
Corporate Officer/Principal presso TRANSGENE
Profilo
James Wentworth is currently the Chief Business Officer & Vice President at Transgene SA. Previously, he worked as the Director of Business Development & Strategy at Adaptimmune Ltd.
He completed his undergraduate and doctorate degrees at the University of Bristol and holds an MBA from the International Institute for Management Development.
Posizioni attive di James Wentworth
| Società | Posizione | Inizio |
|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 22/01/2024 |
Precedenti posizioni note di James Wentworth
| Società | Posizione | Fine |
|---|---|---|
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di James Wentworth
| University of Bristol | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Aziende private | 1 |
|---|---|
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Borsa valori
- Insiders
- James Wentworth
